Inhibition of FGF Receptor Activity in Retinal Ganglion Cell Axons Causes Errors in Target Recognition  by McFarlane, Sarah et al.
Neuron, Vol. 17, 245–254, August, 1996, Copyright 1996 by Cell Press
Inhibition of FGF Receptor Activity
in Retinal Ganglion Cell Axons
Causes Errors in Target Recognition
Sarah McFarlane,* Elsa Cornel,* Enrique Amaya,†‡ be easily amenable to experimental manipulation, thus
providing a very attractive system for studying the mo-and Christine E. Holt*
*Department of Biology lecular mechanisms of axon guidance in the developing
vertebrate nervous system (Holt and Harris, 1993). InUniversity of California, San Diego
La Jolla, California 92093-0366 this system, TK activity is postulated to play a role in
axon extension (Worley and Holt, 1996), arborization†Department of Molecular and Cell Biology
University of California, Berkeley (Cohen-Cory and Fraser, 1995), and the formation of
appropriate topographic connections within the opticBerkeley, California 94720
tectum (Drescher et al., 1995; Cheng et al., 1995). Our
recent findings in Xenopus laevis have implicated the
fibroblast growth factor RTK (FGFR) in axon growth andSummary
guidance in the developing visual system (McFarlane et
al., 1995). We showed that FGF-2 (basic FGF) is presentNative fibroblast growth factor receptor (FGFR) func-
in the developing optic tract, where it may act on FGFRstion was inhibited in developing Xenopus retinal gan-
in retinal ganglion cell (RGC) growth cones to promoteglion cells (RGCs) by in vivo transfection of a dominant
axon growth along the optic pathway. A novel role fornegative FGFR. Axons expressing the dominant nega-
FGF signaling in axon target recognition was indicatedtive protein advanced at 60% of the normal speed, but
by the failure of many RGC axons to innervate theirnevertheless navigated appropriately in the embryonic
target when FGF-2 was applied exogenously to the de-optic pathway. When they neared the optic tectum,
veloping optic projection.however, many axons made erroneous turns, causing
These results raised the intriguing possibility that FGFthem to bypass rather than enter their target. By con-
signaling is important for guiding axons into their target,trast, RGC axons expressing nonfunctional FGFR mu-
but did not directly address an endogenous role fortants entered the tectum correctly. These findings
FGFR activity in this process. Since the exogenous FGFdemonstrate a role for FGFR signaling in the extension
was applied to the entire brain in these experiments, itand targeting of RGC axons and suggest that receptor
could have caused mistargeting by acting on neuroepi-tyrosine kinase/growth factor interactions play a criti-
thelial or tectal cells rather than on RGC axons. To ad-cal function in establishing initial connectivity in the
dress whether presynaptic FGFRs affect target choice,vertebrate visual system.
in the present study we have used a molecular approach
to selectively inhibit FGFR function in RGC growthIntroduction
cones. The function of FGFRs in vertebrate neuronal
connectivity cannot be addressed by the standard geneAxons traveling long distances in the brain receive sig-
knockout method, because FGFRs areessential for earlynals from the local environment that promote their ex-
embryogenesis (Deng et al., 1994; Yamaguchi et al.,tension, direct them along the correct pathway, and
1994). Therefore, we have used a DNA lipofection ap-guide them into their target. Receptors expressed in
proach (Holt, et al., 1990; Lilienbaum et al., 1995), similarthe growth cone provide a necessary link between the
in concept to Drosophila genetic mosaics, which permitenvironmental cues and the growth cone response. One
a functional analysis of FGFR function in single retinalfamily of membrane bound receptors, the receptor tyro-
neurons in the vertebrate CNS without affecting theirsine kinases (RTKs), may transduce cues involved in
local environment. Endogenous growth cone FGFRsneuronal connectivity. For example, the eph family of
were inhibited by transfecting individual RGCs in vivoRTKs are implicated in topographic mapping in the de-
with a previously characterized dominant negativeveloping vertebrate visual system (Henkemeyer et al.,
FGFR construct (Xenopus FGFR deletion [XFD]) (Amaya1994; Drescher et al., 1995; Cheng et al., 1995). In Dro-
et al., 1991, 1993). Our results show that dominant nega-sophila, mutations in derailed, another RTK, cause de-
tive–expressing axons are defective in two key aspectsfects in pathfinding of specific interneurons (Callahan
of their navigational behavior: first, they grow at a sloweret al., 1995). These studies raise the possibility that other
rate than normal; and, second, they often fail to enterRTK families likewise may be important for guiding ax-
their target, the optic tectum, and bypass it instead.ons to their target. Members of the family of growth
These findings strongly implicate axonal FGFRs both infactor RTKs, which are known to transduce signals that
the promotion of extension and in the initial events ofpromote neurite outgrowth in vitro, are likely candidates.
target recognition.However, little is known about the in vivo role of growth
factors, and whether they could be involved in other
aspects of neuronal connectivity, in addition to promot- Results
ing process extension.
The connection formed between the retina and the RGCs Expressing the Dominant Negative
optic tectum, the retinotectal projection, has proven to FGFR Have Abnormally Short Axons
Xenopus RGC growth cones normally express FGFRs
(McFarlane et al., 1995). To determine if FGFR function‡Present address: Wellcome Trust/Cancer Research Campaign
Institute, Tennis Court Road, Cambridge, England CB2 1QR. is important in vivo for outgrowing RGC axons, retinal
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Figure 1. Schematic Representation of FGFR Mutants
The wild-type receptor (XFR) contains a signal sequence (black box),
three extracellular immunoglobulin loops, a transmembrane domain
(hatched box), and a split intracellular tyrosine kinase domain (gray
boxes). The dominant negative construct, XFD, lacks the tyrosine
kinase domain (deletion at amino acid 398) (see arrowhead). D48
encodes a nonfunctional FGFR and, in addition to an intracellular
deletion, has an extracellular deletion of 48 amino acids (between
amino acids 125 and 173) that removes the acid box (white box)
and the three amino acid HAV sequence (Histidine, Alanine, Valine),
but retains a cysteine at position 174, possibly critical for protein
folding. HAVφ is identical to XFD except for a 3 amino acid deletion
of the HAV sequence. This construct does not act as a dominant Figure 2. RGCs Expressing Dominant Negative FGFR Initiate Axons
negative for FGF signaling, butdoes function as a dominant negative RGCs in 50-mm thick vibratome sections of the eye of stage 40
for a novel non-FGF ligand of the FGFR (Kinoshita et al., 1995). Xenopus embryos transfected at stage 19.
(A)–(B) RGC transfected with the dominant negative FGFR (XFD)
and visualized with an anti-FGFR antibody. (B) is a higher powerprecursors were transfected with a dominant negative
view of (A).
truncated form of the FGFR (XFD) (Figure 1) (Amaya (C) RGC transfected with the reporter gene CS2-Luciferase and
et al., 1991, 1993). This mutant receptor blocks FGF- visualized with an anti-luciferase antibody.
stimulated Ca21 release from Xenopus oocytes, and is (D) RGC transfected with the nonfunctional FGFR (D48) and visual-
ized with an anti-FGFR antibody. With all three constructs,thought to inhibit endogenous FGFRs via FGF-stimu-
transfected RGCs extend axons. vs, vitreal surface; onh, optic nervelated formation of nonfunctional heterodimers with na-
head; PE, pigment epithelium. Scale bar, 30 mm for (A); 10 mm fortive receptors (Amaya et al., 1991). As controls, a lucifer-
(B)–(D).
ase reporter construct (CS2-Luc) (Holt et al., 1990;
Lilienbaum et al., 1995) and two nonfunctional FGFR
mutants, D48 and HAVφ, were used to transfect RGCs immunostained in wholemount, and transfected cells
and their axons were analyzed in serial vibratome sec-(Figure1). In addition toa large intracellular deletion, D48
contains a 48 amino acid deletion, and HAVφ contains a tions through the eye and the brain. Luciferase-express-
ing cells were visualized with an anti-luciferase antibodythree amino acid deletion (Histidine, Alanine, Valine)
(HAV) in the extracellular domain of the receptor (Amaya (Holt et al., 1990) (Figure 2C), whereas an anti-Xenopus
FGFR antibody (Amaya et al., 1993) was used tovisualizeet al., 1991, 1993). HAVφ and D48 are unable to mediate
FGF binding and receptor dimerization; therefore, they cells expressing the three FGFR constructs (Figures 2A,
2B, and 2D). A myc-tagged version of XFD was alsodo not function as dominant negatives for FGF-mediated
processes (Amaya et al., 1993). However, HAVφ and used, and cells expressing this construct were identified
using the anti-myc antibody, 9E10 (Evan, et al., 1985).XFD recently have been shown to act as dominant nega-
tivemutants for a non-FGF ligand of the FGFR, indicating The FGFR mutants were expressed in large excess of
levels of endogenous FGFR expression, and, therefore,that HAVφ may not always be a nonfunctional construct
(Kinoshita et al., 1995). the cell bodies and axons of transfected neurons were
easily identifiable over the background staining owingDNA constructs mixed with the lipofection agent
DOTAP were injected into the proliferating neuroepithel- to endogenous FGFR labeling (Figure 2; see Figure 5).
At higher antibody concentrations, the endogenousium that gives rise to the eye at embryonic stage 19,
and the embryos were fixed z48 hr later at stage 40. staining was evident (McFarlane et al., 1995).
When eye primordia were transfected with the domi-By stage 40, many RGC axons have grown out of the
eye, into the brain, and innervated the optic tectum (Holt, nant negative FGFR, RGCs expressing XFD made up
the same percentage of transfected retinal cells (16%,1989), and expression of the transfected genes are at
their highest levels (Holt et al., 1990). Embryos were n 5 417) as when retinal precursors were transfected
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with either of the two nonfunctional mutants, D48 (19%,
n 5 168) or HAVφ (21%, n 5 476). RGCs were identified
on the basis of morphology and laminar position. No
XFD-transfected cells were obviously pycnotic, and
XFD-expressing RGCs were observed as late as stage
45, 4 days after injection. These data suggest that FGF
signaling is not required for specifying the identity of
RGCs, for controlling their migration to the appropriate
retinal laminae, or for their short-term survival.
Almost all RGCs expressing the nonfunctional D48
or luciferase transgenes initiated axons (see Figure 2;
Figure 3A), many of which reached the optic tectum
(D48, 47%, n 5 73; CS2-Luc, 50%, n 5 32) (Figure 3C).
The majority of RGCs expressing thedominant negative,
XFD (86%, 137/159), also sent out an axon; however,
these axons were significantly shorter than those ex-
tended by RGCs expressing D48 or CS2-Luc (p<0.001,
Kruskal-Wallis Nonparametric ANOVA Test) (Figure 3B).
In fact, 44% (n 5 137) of mutant-expressing axons never
exited the eye, and only a minority grew as far as the
target region (13%, n 5 137) (Figure 3C). Similar results
wereobserved with the myc-tagged version of XFD (data
not shown). To address whether XFD-expressing axons
that grew out to the target actually entered the optic
tectum, we examined transfected axons in wholemount
preparations. These data suggest that decreasing FGFR
activity inhibits axon elongation in the optic pathway.
Surprisingly, only 37% (n 5 168) of RGCs expressing
the HAVφ mutant sent out an axon (Figure 3A). Since
almost all XFD-expressing RGCs extended axons, the
HAVφ construct may interfere with axon initiation by
blockingan FGF-independent process. The mean length
of HAVφ axons was reduced slightly in comparison with
control D48 and CS2-Luc axons (Figure 3B), reflecting
a population of short axons in the optic pathway in the
eye (29%, n 5 62) (Figure 3C). Interestingly, when we
considered for each transgene the percentage of
transfected axons that, having exited the eye, grew out
to the target, over half of the HAVφ-expressing axons
extended as far as the tectal area (56%, n 5 41), similar
to the growth of RGC axons expressing the nonfunc-
tional D48 (51%, n 5 67) and CS2-Luc (61%, n 5 26)
transgenes. In contrast, only 24% (18/76) of XFD-ex-
pressing axons that exited the eye reached the target
Figure 3. Inhibiting FGF Signaling Decreases Retinal Axon Lengtharea by stage 40. These results indicate that HAVφ pri-
(A) Percentage of RGCs that express either XFD, D48, HAVφ, ormarily compromises axon initiation and extension within
CS2-Luc that have initiated an axon greater than one cell indiameter.
the eye. The number of RGCs is indicated in brackets.
To address the possibility that the short length of (B) Average length of RGC axons transfected with each of the con-
the dominant negative–expressing axons arises as an structs as measured from reconstruction of vibratome sections.
Axon trajectories were localized in the optic pathway and plottedartifact owing to the failure of the XFD protein to be
on a normalized brain to eliminate variability in brain size. In manytransported to the axon tip, only the lengths of dominant
retinae, several RGCs were transfected; therefore, it was often notnegative–expressing axons with obvious growth cones
possible to trace a given axon back to its cell body. As a result,were evaluated (61%, n 5 107), and a similar reduction
axonal lengths were measured relative to the beginning of the optic
was found (293 mm 6 27 mm). It is also unlikely that a nerve head. Thus, RGCs with axons on the vitreal surface and those
decrease in axon length can be explained by growth without axons were not included in this analysis. The Kruskal-Wallis
cone collapse due to late onset of expression of the Nonparametric ANOVA test was used to compare each sample
(three asterisks, p<0.001; Dunn’s multiple comparison test as theprotein. Time-lapse recording of XFD-myc-expressing
posthoc analysis). Numbers in brackets indicate the number of ax-axons in vitro shows that even when XFD is expressed
ons and error bars are SEM.in the body, lamellipodia and filopodia of transfected
(C) The data for all axons expressing either XFD, HAVφ, or D48 were
RGC growth cones, they are still motile (see below) (Fig- plotted in bins representing different axon lengths. Axons on the
ures 4B and 4C). Thus, consistent with our previous data vitreal surface (vs) and shorter than 100 mm are within the retina,
showing that FGF-2 stimulates neurite extension of RGC whereas axons longer than 500 mm (1500) have reached the tectum.
n is the number of axons.axons in vitro (McFarlane et al., 1995), the short length
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the speeds of untransfected RGC growth cones and
RGC growth cones expressing either a myc-tagged ver-
sion of the mutant XFD protein (XFD-myc) or green fluo-
rescent protein (GFP) (or both) were measured in vitro.
Eye primodia removed from stage 22 embryos were
cotransfected with XFD-myc and GFP DNA, or trans-
fected with GFP alone, and then cultured as explants
for 48–72 hr. Prior to recording, the culture dishes were
rinsed and incubated with L15 media and 0.1% bovine
serum albumin. Growth cones were then recorded either
with or without 20 ng/ml FGF-2, or with 20 ng/ml brain-
derived neurotrophic factor (BDNF). FGF-2 at this con-
centration stimulates retinal neurite outgrowth in disso-
ciated eye cultures (McFarlane et al., 1995), and BDNF
promotes the survival of cultured Xenopus RGCs (Co-
hen-Cory and Fraser, 1994). GFP-positive growth cones
were followed with time-lapse videomicroscopy. After
recording, we confirmed that these growth cones were
XFD-positive by immunolabeling with anti-myc (see Fig-
ures 4A and 4B).
In the presence of FGF-2, RGC axons with impaired
FGFR activity grew at 38 mm/hr, z60% of the speed of
untransfected or GFP-only-expressing axons (Figures
4C and 4D). In the absence of FGF-2, all growth cones
grew at a similarly reduced speed (Figure 4D). Because
XFD had no effect on outgrowth stimulated by BDNF
(Figure 4D), a growth factor that works through dimeriza-
tion of trk B, it is unlikely that this mutant FGFR is inhib-
iting axon extension or growth factor RTK signaling in
a nonspecific manner. The demonstration that XFD can
specifically inhibit FGF-stimulated events, but has no
effect on BDNF-stimulated outgrowth, is important as
it indicates that XFD can act as a dominant negative
FGFR in Xenopus retinal neurons. Half of the XFD-myc-
expressing growth cones (10/20) in FGF-2 grew at aFigure 4. Inhibiting FGFR Function Decreases Growth Cone Speed
steady but slow rate, while the rest exhibited saltatory(A) and (B) Stage 22 eye primordia were cotransfected with GFP
growth. GFP-transfected growth cones also exhibitedand XFD-myc cDNAs and plated as explants for 48–72 hr to allow
these two growth modes in FGF-2, with 62% (n 5 16)time for expression of the constructs. The growth of the GFP(1)
RGC growth cone in (A) was recorded in the presence of 20 ng/ml extending at a constant speed. The time-lapse data
FGF-2 with time-lapse videomicroscopy. The culture was then fixed strongly suggest that inhibiting endogenous FGFR sig-
and stained with anti-myc to confirm that the growth cone was naling results in shortened axons in vivo, because they
coexpressing the myc-tagged XFD (B).
grow more slowly, not because RGCs expressing the(C) The distance (mm) extended by the XFD-expressing growth cone
mutant are delayed in axon initiation. Further supporting(squares) in (A) as a function of time (min), as compared with a
this idea is the observation in vivo that at stage 35/36control, untransfected growth cone from the same culture dish
(circles). (24 hr earlier than stage 40), XFD- and control D48–
(D) Average growth cone speed for control untransfected, GFP expressing RGCs make up a similar percentage of trans-
transfected, and for XFD/GFP cotransfected RGC growth cones fected retinal neurons (XFD: 17%, n 5 210; D48: 13%,
recorded with or without 20 ng/ml FGF-2, or with 20 ng/ml BDNF.
n 5 154), and comparable numbers of these RGCs haveThese results indicate that XFD can inhibit FGF-2- (three asterisks,
initiated axons (XFD: 86%, n 5 36; D48: 84%, n 5 21).p<0.001, unpaired, two-tail Student’s t test), but not BDNF-stimu-
lated RGC axon extension. Number of growth cones is indicated,
and error bars represent the SEM. Data is from 9 separate platings.
Scale bar, 5 mm. Pathfinding Behavior Mostly Normal Despite
Inhibition of FGFR Function
RGC axons take a stereotypic route to their target. In
of XFD-expressing retinal axons supports the idea that the eye, the axons grow across the vitreal surface, ex-
signaling through the FGFR promotes extension of optic tend into the optic nerve head, and exit via the optic
axons in the pathway. nerve. In the brain, axons cross the midline at the optic
chiasm, grow dorsally, and, midway through the dien-
cephalon, turn caudally and grow towards the optic tec-Decreasing FGFR Function Slows Down
RGC Growth Cones tum (Holt, 1989). To examine whether axonal FGFRs are
required for pathfinding in the retina and the optic tract,An alternative explanation for shortened XFD-express-
ing axons is that inhibiting FGFRs in RGCs delays axon transfected RGC axons were visualized at stage 40 in
serial vibratome sections, and in wholemount brainsinitiation. To directly measure the rate of axon growth,
Inhibition of FGFR Activity in Developing Retinal Ganglion Cells
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Figure 5. Normal FGFR Activity Is Required for Axon Targeting
Lateral view of stage 40 wholemount brains showing axons transfected either with CS2-Luc (A and C), HAVφ (D), or with XFD (B, E, and F).
Axons were visualized with anti-luciferase in (A) and (C), with anti-FGFR in (B), (D), and (E), and with anti-myc in (F). (C) and (E) are higher
power views of (A) and (B), respectively (boxed area in [A]). The dotted line approximates the rostral tectal border (see text). Axons expressing
the luciferase reporter construct make a caudal turn in the mid-diencephalon (Di) and grow into the tectum where they stop and arborize.
The axon with impaired FGFR signaling in (B) is able to pathfind correctly, making the turn in the mid-diencephalon. This axon appears to
branch prematurely in the ventral diencephalon (B and E). While some axons expressing the dominant negative FGFR enter the tectum (see
Figure 6), others veer aberrantly near the tectal border and grow dorsally (E) or ventrally (F) around the tectum. D, dorsal; V, ventral; Pi, pineal;
Di, diencephalon; Tec, tectum. Scale bar, 100 mm for (A)–(B); 40 mm for (C)–(F).
with respect to specific brain landmarks (see Figure 2; Since theonset of XFD expression mayvary with respect
to the time of process initiation and outgrowth, it isFigure 5). The majority of XFD-expressing retinal axons
exhibited normal pathfinding, as did all the axons possible that axons showing normal pathfinding are not
yet expressing significant levels of the mutant protein.transfected with control constructs. A few axons (<10%)
expressing the dominant negative FGFR showed path- Given the number of pathway choices these axons en-
counter, however, the very low number of pathfindingfinding errors, growing dorsally rather than ventrally in
the eye (n 5 9), abruptly changing direction in the optic errors suggests that FGFRs are not required for retinal
axons to select the correct path.tract (n 5 3), or growing very anteriorly in the diencepha-
lon (n 5 12). The number of cases for each pathfinding Newly extended RGC axons occasionally bifurcate
within, but rarely outside, the retina (Holt, 1989). Thisdefect is small, but no similar behaviors were observed
for axons transfected with any of the control constructs. was the case for axons transfected with the luciferase
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sections, whereas for HAVφ and D48 these axons repre-
sented z40% and 50% of the populations respectively.
Figure 5 and Figure 6 show examples of the behavior
of axons expressing the various transgenes as they
reach the tectum. We used three reliable morphological
landmarks to identify the anterior border of the tectum:
the point where the second ventricle enlarges into the
third, the posterior border of the neuropil of the tract of
the posterior commissure, and the positionof the dorso-
lateral isthmus between the diencephalon and midbrain
(see dotted lines in Figure 5 and Figure 6). Almost all
the axons reaching the target and expressing control
luciferase, HAVφ, or D48 constructs entered and arbo-
rized in the tectum (Figure 6E). In contrast, inhibiting
FGFR activity with XFD caused many axons (41%, n 5
126) to fail to innervate the target (Figure 6E). Axons
showing mistargeting turned, sometimes quite abruptly,
near the tectal border and continued growing in either
dorsal or ventral directions around the tectum (see Fig-Figure 6. Axons Expressing the Dominant Negative FGFR Display
ures 5E and 5F; Figure 6D). The remaining axons grewTargeting Errors and Aberrant Early Branching
into the target (Figure 6D). The specificity of the XFD(A)–(D) Camera lucida representations of the tectal border region
dominant negative effect on target recognition is indi-(boxed area in Figure 5A) of wholemount brains immunostained for
axons transfected with CS2-Luc (A), D48 (B), HAVφ (C), and XFD cated by the fact that the HAVφ protein, which differs
(D). Dotted line indicates the approximate anterior tectal border. from XFD by only three amino acids, when overex-
Only axons expressing XFD mistarget (D), turning at the border and pressed in retinal growth cones at comparable levels
veering either dorsally (star) or ventrally (triangle) along the tectal
with XFD has no effect on RGC axonal targeting. Theseborder. Other axons enter the tectum correctly (circle). In addition,
results indicate that FGFRs transduce a signal, possibly33% of XFD-expressing axons branch aberrantly before they reach
an FGF ligand, that is involved in targeting of retinalthe tectum (arrows).
(E) Percentage of wholemount RGC axons expressing either XFD, axons into the optic tectum.
D48, HAVφ, or CS2-Luc that fail to enter the target and, instead, The behavior of XFD-expressing axons might depend
grow along its borders. Only axons that had reached the tract/tectal on how much of the mutant receptor is expressed
junction and had made a targeting decision were considered in this
and, thus, to what degree their FGFR activity is inhibited.analysis. Approximately 40% of axons expressing XFD mistarget.
To examine this possibility, immunolabeling of XFD-Tec, tectum; Di, diencephalon; D, dorsal; V, ventral. Numbers in
expressing axons was evaluated on the basis of stainingbrackets represent the number of axons.
intensity; axons were assigned a value on a scale of 1–3
(1 corresponded to faintly stained axons and 3 to darkly
stained axons). When the behavior of the most darkly(4/109) or nonfunctional D48 (3/41) constructs. In con-
labeled axons was considered, presumably correspond-trast, a significant number of axons expressing the XFD
ing to the highest levels of XFD protein expression, overmutant protein bifurcated either in the optic tract (Figure
half were short and had not yet reached the target (31/5B) or close to the tectal border (33%, 42/126) (Figure
57). For the remaining intensely labeled axons that had6D). While it is possible that branching could be
grown as far as the tectum and made a targeting deci-mistaken for defasciculation of two axons, abnormal
sion (n 5 26), a mistargeting phenotype was seen inbranching was seen in cases where XFD-expressing
73% of the cases.axons could be traced back to individual RGC cell bod-
ies. This was not true of axons expressing one of the
control transgenes. One explanation for the aberrant
Discussion
branching is that a premature decrease in FGFR signal-
ing may mimic the decrease in FGF-2 at the tract/tectal
In this study, we demonstrate that the FGFR is onejuncture and thus initiate branching/arborization behav-
of the receptors in RGC growth cones that transducesior normally seen only in the optic tectum.
environmental cues required for the formation of the
retinotectal projection. A mutant FGFR that blocks the
function of endogenous FGFRs was used in vivo to showRetinal Axons Expressing the Dominant Negative
FGFR Fail to Enter the Tectum the importance of retinal growth cone FGFR signaling
both for normal extension in the optic pathway and tar-The finding that exogenously applied FGF-2 causes
RGC axons to ignore their target raises the possibility get recognition.
Axons need cues that tell them to grow, steer, andthat FGFRs play a role in the selection of and entry
into the tectum (McFarlane et al., 1995). Therefore, we stop once they arrive at their target. Our data indicate
that in the developing Xenopus visual system signalinganalyzed in wholemount the behavior of axons that had
extended as far as the tectum at the time of fixation. through the FGFR is involved in two of these proces-
ses: extension and target recognition. Previously, weFor XFD-expressing axons, this represented a small per-
centage (15%) of the entire population of axons as deter- showed that FGF-2 stimulates retinal neurite extension
in vitro and causes mistargeting of retinal axons whenmined from the aforementioned analysis of vibratome
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applied exogenously to the developing optic projection phenotype. One simple interpretation for the similar phe-
notypes, based on data showing that FGFs can inhibit(McFarlane et al., 1995). The transfection experiments
presented in the present study provide direct evidence FGFR activity (Williams et al., 1995), is that FGFR signal-
ing is impaired in both cases. However, our data supportfor an in vivo role for FGFRs in neuronal connectivity.
The abnormally short length of XFD-expressing axons the idea that exogenous FGF-2 activates the FGFR;
FGF-2 causes target recognition errors in vivo at con-suggests that FGFR signaling is normally involved in the
extension of RGC axons along the optic pathway. FGF-2 centrations that cause stimulation of retinal neurite ex-
tension in vitro (McFarlane et al., 1995), and unlike XFD-is a candidate growth-promoting ligand for the receptor
based on its presence in the developing optic tract and expressing axons, FGF-2-treated axons in vivo show
no defects in extension, and, in fact, grow further thanon its stimulation of retinal neurite extension in culture
(McFarlane et al., 1995). Indeed, we show that inhibiting normal.
Thus, it seems that mistargeting can result from eithergrowth cone FGFR activity decreases FGF-2-stimu-
lated, but not BDNF-stimulated, retinal neurite out- a sustained increase or decrease in FGFR activity. This
leads to a model based on the idea that retinal growthgrowth in vitro to a degree that is similar to axons grow-
ing in the absence of FGF-2 ligand (McFarlane et al., cones recognize their target in part by responding to
changes in FGFR signaling that occur at the tectal bor-1995). A reduction in growth rate owing to a loss of an
FGF signal could explain the short length of domi- der. There are several ways that FGFR signaling could
be altered: first, a change in FGF concentration, suchnant negative–expressing axons observed in vivo. While
FGFsare knownto stimulate neurite outgrowth inculture as a drop in FGF-2 levels at the tract/tectal juncture;
second, a switch to a new FGFR ligand; and third, a(Hatten, et al., 1988; Lipton et al., 1988; Rydel and
Greene, 1987; Walicke et al., 1986; Walicke, 1988), our new HS cofactor altering the activity of the high-affinity
FGF RTK. Since our previous work is consistent withcurrent data indicate that in vivo, signaling via FGFRs
promotes axon extension. Despite their slower growth the notion that FGF and HS levels drop at the target
(McFarlane et al., 1995; A. Walz, unpublished data), werates, almost all axons whose FGFRs are inhibited make
appropriate pathfinding decisions and grow within the favor the idea that a change in FGF signaling notifies
axons that they have arrived at their target by slowingoptic tract. It is only when they near the target that
aberrant behavior is exhibited, with many of the axons their advancement and switches them from a growing
mode into an arborizing mode. Indeed, in vivo time-not entering the tectum but turning abruptly and skirting
its dorsal or ventral borders. That FGF signaling plays lapse microscopy indicates that Xenopus RGC axons
slow down and alter their behavior dramatically uponno significant role in axon pathfinding is supported by
the fact that bathing the entire brain with exogenous reaching the tectum (Harris et al., 1987). The similar
phenotypes observed for exogenous FGF-2 applicationFGF-2, which presumably eliminates regional differ-
ences in FGF-2 levels, has no effect on the steering of and dominant negative inhibition of RGC FGFR activity
argue that it is a rate change, not simply slowed growth,axons in the optic tract (McFarlane et al., 1995).
The mistargeting of retinal axons exposed to exoge- that is requisite for axonal targeting. In both cases, ax-
ons are impaired in their ability to register a FGF concen-nously applied FGF-2 has implicated FGFR signaling in
target recognition (McFarlane et al., 1995). This previous tration difference, either because the difference is
swamped by exogenous FGF-2 or not registered whenstudy, however, did not address whether FGFR activity
is involved normally in target recognition, nor whether FGFRs in RGC axons are inhibited by overexpression
of XFD. Thus, although the axons grow at differentaxon misrouting was caused indirectly by FGF-2-in-
duced changes to the neuroepithelium. The mistar- speeds, in neither situation do they alter their growth
rate on nearing the tectum, and consequently fail togeting of XFD-expressing axons provides good evi-
dence that axonal FGFRs play an endogenous role in switch from a growing mode. As a result, oblivious to
their normal target, the retinal axons continue extendingtarget recognition. Further, several pieces of data point
toan FGFas the ligand involved. First, exogenous FGF-2 inappropriately within growth stimulatory regions ante-
rior and ventral to their normal target. Previously, otherscauses axon mistargeting, as do FGF-2-binding but not
FGF-1-binding brain-derived heparan sulfates (HSs) have postulated that changes in growth factor levels
upon reaching the target are important for normal in-(Nurcombe et al., 1993; A. Walz, unpublished data). Sec-
ond, axons expressing HAVφ, a mutant FGFR shown nervation (Hoyle et al., 1993; Zhang et al., 1994; ElShamy
et al., 1996). For instance, the innervation of PNS targetsto be incapable of inhibiting FGF-dependent signaling
(Amaya et al., 1993), enter the tectum normally. The by sympathetic axons depends on growth cones being
able to register a nerve growth factor (NGF) concentra-FGF-2 expression pattern (McFarlane, et al., 1995) and
the mistargeting caused specifically by FGF-2-binding tion difference at the target (Hoyle et al., 1993). Sympa-
thetic axons transgenically altered to express and se-HSs (A. Walz, unpublished data) are suggestive of a
particular role for FGF-2 in axonal targeting. Interest- crete NGF fail to innervate their unmodified targets,
presumably because the growth cones exposed to ex-ingly, FGF-3 and eFGF mRNAs are expressed in the
posterior tectum, raising the possibility that a posterior cess NGF are blinded to endogenous gradients. That
innervation can be restored if a target is made to overex-to anterior difference of either FGF in the tectum could
function in target recognition (Tannahill et al., 1992; press NGF supports this idea.
In contrast with the strong penetrance of the mistar-Isaacs et al., 1995). Any explanation of how FGFs are
involved in target recognition must take into account geting phenotype produced by exogenous application
of FGF-2, many of the axons with impaired FGFR func-that both providing exogenous ligand and inhibiting re-
ceptor activity results in the same aberrant targeting tion that reach the tectum target correctly. Innervation
Neuron
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may simply reflect insufficient XFD inhibition of FGFR instance, the lack of influence of the HAVφ protein on
axon entry into the tectum, in addition to the mistar-activity at the time those axons are reaching the target.
geting caused by exogenous FGF-2 and FGF-2 bindingIndeed, only 30% of the most highly immunolabeled
HSs, implicates FGF signaling in target recognition. Inaxons enter the tectum. Alternatively, given the probable
comparison, the inhibition of axonogenesis observedredundancy of cues involved in target recognition, it
only with HAVφ indicates that axon initiation and exten-may not be surprising that many XFD-expressing axons
sion within the eye is not an FGF-dependent process.innervate the target. Recently, it has been argued that
The ability of both XFD and HAVφ to inhibit axon exten-removal of a single target recognition cue from a popula-
sion within the eye raises the interesting possibility thattion of organized signals may be a less effective stimulus
several ligands act via the same receptor to promotethan the ectopic disorganized overexpression of that
axon growth. Why XFD does not similarly inhibit axonsame protein (Nose et al., 1994; Chiba et al., 1995). In
initiation is puzzling, but may reflect some critical func-Drosophila, the phenotype of a genetic knockout of a
tion of the HAVφ sequence. The importance of the HAVsingle protein involved in axon guidance or target recog-
sequence for protein–protein interactions may hint at anition (or both) is often not fully penetrant (Nose et al.,
mechanism; the HAV domain has been postulated to1994; Lin and Goodman, 1994; Desai, et al., 1996). This
mediate homophilic interactions between cadherin mol-argues for redundancy in the signaling mechanisms and
ecules (Blaschuk et al., 1990) and heterophilic interac-indicates that other molecules, in addition to FGFRs,
tions between the FGFR and both cadherin (Williams etare important for target recognition.
al., 1994) and heparin (Byers et al., 1992). RegardlessXFD is thought to exert its effects by forming nonfunc-
of the actual ligand(s), our data strongly suggest thattional heterodimers with endogenous FGFRs in re-
FGF RTKs play a role in vivo in RGC axon extension andsponse to ligand binding (Amaya et al., 1991, 1993), and
target recognition. In the future, it will be interesting tofunctions in Xenopus embryos as a dominant negative
determine the link that the FGFR makes between spe-for FGFR involvement in both mesodermal and neural
cific extracellular signals and the intracellular mecha-induction (Amaya et al., 1991, 1993; Launay et al., 1996).
nisms of axon growth and guidance.The specific inhibition of FGF-stimulated, but not BDNF-
stimulated, neurite extension in retinal explant cultures
Experimental Proceduressuggests that XFD similarly is acting as a dominant neg-
ative in the Xenopus retinal system. As has been demon- Animals
strated for chick (Ueno et al., 1992), XFD is probably Embryos wereattained by fertilizing eggs obtained from adult female
capable of inhibiting all of the wild-type Xenopus FGFRs, X. laevis injectedwith human chorionic gonadotropin. Embryos were
kept in 10% Holtfreter’s solution (Holtfreter, 1943) with the tempera-of which three FGFR families have been cloned (Musci
ture varied between 148C and 278C to control their speed of develop-et al., 1990; Friesel and Dawid, 1991; Friesel and Brown,
ment. Embryos were staged according to Nieuwkoop and Faber1992; Shiozaki et al., 1995; Riou et al., 1996). Messenger
(1967). For DNA injections, embryos were anaesthetized in Modified
RNAs for both FGFR-1 and FGFR-2 are expressed in Barth’s Saline (88 mM NaCl, 1 mM KCl, 0.7 mM CaCl2, 1mM MgS04,
developing chick RGCs (Tcheng et al., 1994), and 5 mM HEPES (pH 7.8), 2.5 mM NaHC03) supplemented with 0.4 mg/
ml tricaine (ethyl 3-aminobenzoate methanesulfonic acid) (AldrichXFGFR-2 and XFGFR-4B mRNA are expressed in the
Chemical Company, Inc., Milwaukee, WI).developing Xenopus eye primordium (Friesel and
Brown, 1992; Riou et al., 1996). Whether one or several
Constructs
receptors are involved in transducing the cues involved RNA constructs encoding the dominant negative (XFD) andnonfunc-
in extension and target recognition remains to be deter- tional D48 and HAVNOT (HAVφ) FGFR receptors have been de-
mined. scribed previously (Amaya et al., 1991, 1993). An XFD containing a
single C-terminal myc tag was generated (XFD-myc). These fourWhile it is clear from our data that FGFRs play a role in
constructs were subcloned into a modified CS2-DNA vector (thethe formation of the retinotectal projection, the ligand(s)
original CS2 vector was a gift of D. Turner). Figure 1 is a schematic
involved is still open to debate. The mistargeting pheno- diagram of the FGFR constructs. A luciferase reporter gene (Holt et
type produced by FGF-2 and HS application and the al., 1990) was also subcloned into CS2 (provided by R. Riehl) and
FGF-2 immunolocalization data strongly mark FGFs as used along with a CS2 cDNA construct encoding GFP (gift of D.
Turner) as controls. Plasmids were purified from Escherichia coliparticipants. It is also possible that non-FGF molecules
using the Qiagen Maxi-prep kit.signal via growth cone FGFRs. The strongest support
for this idea comes from the HAVφ construct, which we
DNA Lipofections
show impairs axon initiation and extension within the The DNA lipofection technique has been described previously (Holt,
eye. A candidate group of non-FGF FGFR interactors 1990; Lilienbaum et al., 1995). In brief, DNA was mixed with a syn-
thetic cationic lipid, DOTAP (Boehringer Mannheim, Indianapolis,are the cell adhesion molecules (CAMs). CAMs are ex-
IN) at a ratio of 1:3. A borosilicate glass needle, pulled on an elec-pressed in the developing optic tract (see review by
trode puller (Sutter Instrument Company, Novato, CA), was usedBixby and Harris, 1991), and they have been postulated
with a Picospritzer II (General Valve Corporation) to make multiple
to promote axon extension via a CAM homology domain extracellular injections of this mixture into the developing eye pri-
in the FGFR (Williams et al., 1994). Alternatively, novel mordia of stage 19 embryos. Embryos were allowed to develop at
non-FGF ligands recently have been cloned for the room temperature for 48 hr in 10% Holtfreter’s until stage 40 and
were then fixed overnight in 4% paraformaldehyde in 0.1 M PO4FGFR, one of which is expressed in the developing eye
buffer at 48C.primordium of Xenopus (Kinoshita et al., 1995). Thus,
FGFRs in RGC growth cones may be activated by FGFs,
Immunocytochemistry
non-FGF molecules, or a combination of both. The The skin was dissected from the injected eye and brain, and the
HAVφ mutant may be useful in determining which li- lens of the eye was removed to facilitate antibody penetration. Em-
bryos were immunostained in wholemount as described previouslygand(s) are involved for the different processes. For
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(Lilienbaum et al., 1995). In brief, embryos were incubated in primary to reduce illumination intensity. GFP-positive growth cones were
recorded for 30–90 min using a Cohu 4915 video camera at 483antibody overnight, rinsed, and then incubated in secondary anti-
body overnight. Antibody-treated embryos were incubated in 0.5% time-lapse with a Mitsubishi HS-55600 SVHS time-lapse VCR. After
recording, cultures were fixed in 4% paraformaldehyde for 1 hr atdiaminobenzidine (Sigma) for 30 min at which point 1% hydrogen
peroxide was added to catalyze the peroxidase reaction. Embryos room temperature, left overnight in methanol at 2208C, immuno-
stained for c-myc, and viewed with the inverted microscope underwere post-fixed for 1 hr in 1% gluteraldehyde at room temperature
and processed as wholemounts, or embedded in gelatin-albumin, epifluoresence to confirm the coexpression of XFD and GFP. For
analysis, length measurements were taken from the video screenand 50 mm vibratome-sections were cut (Oxford). Wholemount
brains and vibratome sections were dehydrated through a series of at 5 min intervals and processed using Excel (Microsoft).
alcohols. Vibratome sections were additionally cleared inXylene and
mounted under a glass coverslip with Permount (Fisher Scientific Acknowledgments
Company, Pittsburgh, PA). Wholemount brains were cleared in 2:1
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